Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma

Size: px
Start display at page:

Download "Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma"

Transcription

1 Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma Kelly Endean PhD Scientific Affairs Manager, The Binding Site

2 Focus of this talk An introduction to heavy-light chain (HLC) analysis & its benefits Hevylite in MGUS Prognosis Hevylite in multiple myeloma Presentation Monitoring Prognosis

3 Detection of Monoclonal Proteins Monoclonal Intact Immunoglobulins Serum electrophoresis or Serum HLC (Hevylite) Monoclonal Free Light Chains Urine electrophoresis or Serum FLC

4 IMWG guidelines: Multiple myeloma follow-up For patients with measurable monoclonal protein in serum, both electrophoretic studies and quantitative immunoglobulins are recommended to assess response, although electrophoretic measurements to follow monoclonal protein are preferred. Dimopoulos et al Blood 117(18),

5 Limitations of electrophoresis Some serum protein electrophoresis (SPE) results are difficult to interpret Broad bands & smearing of bands Couplet/ triplets of bands Precipitation at the point of application Dye saturation Hidden bands

6 NHS Problems with SPE densitometry IgA bands may be hidden by transferrin 14 IgA Multiple Myeloma sera Alb

7 IMWG guidelines: Multiple myeloma follow-up For patients with measurable monoclonal protein in serum, both electrophoretic studies and quantitative immunoglobulins are recommended to assess response, although electrophoretic measurements to follow monoclonal protein are preferred. For several patients, especially with IgA or IgD myeloma, nephelometric quantitation of serum immunoglobulin is necessary. Dimopoulos et al Blood 117(18),

8 Standard nephelometric IgG, IgA and IgM assays Total immunoglobulin measurements do not distinguish monoclonal from polyclonal proteins within any given sample e.g. Total IgG = IgG + IgG involved immunoglobulin + uninvolved immunoglobulin

9

10

11

12 Prognostic value of Hevylite in MGUS IgG Heavy-Light Chain Pair suppression is an indicator of progression from MGUS to MM IgA IgA Involved Ig & uninvolved Ig Katzmann et al. Blood 2009; 114: 1788

13 Prognostic value of Hevylite in MGUS IgG Heavy-Light Chain Pair Suppression is an indicator of progression from MGUS to MM IgA IgA HLC pair suppression Involved Ig & uninvolved Ig Katzmann et al. Blood 2009; 114: 1788

14

15 Study population of 999 MGUS patients Follow-up over 30 years HLC pair suppression is an independent risk factor for progression Katzmann et al Leukemia 2012

16

17

18

19 Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG (Bradwell et al. 2009) IgA (Donato et al. 2011) Prognostication

20 Mirbahai et al. Presented at AACC 2011

21 NHS Problems with SPE densitometry IgA bands may be hidden by transferrin 14 IgA Multiple Myeloma sera Alb

22 IgG MM patients have an abnormal IgG HLC ratio at presentation IgG (g/l) N = 245 IgG (g/l) Bradwell et al Leukemia 2012; doi: /leu

23 Hevylite IgG /IgG ratios Correct for variable IgG metabolism

24 Concentration-dependent catabolism of IgG

25 Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG IgA (Donato et al. 2011) Prognostication

26 Avet-Loiseau et al. Haematologica (s1): P-393a

27 IgG HLC: Monitoring IgG MM IgG HLC ratio is normal when IFE is positive for some IgG patients? Hevylite ratio insensitive due to background IgG? IFE is false positive due to recycling by FcRN receptor

28 IgGk production by tumour IgGk serum concentration IFE positivity remains due to IgG recycling IFE Short IgG half-life Prolonged IgG half-life Time

29

30 Discrepancies between IFE & bone marrow immunophenotype Discrepancies between the three techniques were relatively common... in all seven patients achieving IR [Bone marrow plasma cell immunophenotypic response] but remaining immunofixation positive, the M-component disappeared in follow-up analysis. Paiva et al. J Clin Oncol 2011;29:

31

32 Clinical History 9 yr history of MGUS Presentation Anaemia and hypercalcaemia SPE - 48 g/l M protein IFE monoclonal IgAκ Raised total IgA (47.2g/L) Abnormal sflc κ/λ ratio (7) BM - 40% plasma cells Donato et al. Clin Chem. 2011;57(12):1645-8

33 Diagnosis MM (Durie-Salmon stg IIIA/Int stg 2) Treatment & monitoring Stem cell transplant Pt became asymptomatic Electrophoresis negative for 1.5 yrs 1 st relapse 2 yrs following ASCT Donato et al. Clin Chem. 2011;57(12):1645-8

34

35

36 Monoclonal proteins that migrate as broad bands can be difficult to distinguish, and quantitative assessment of immunoglobulin HLC pairs provides a measure of clonal synthesis. Donato et al. Clin Chem. 2011;57(12): Commentary - James D. Faix, Stanford University Now it is clear that we have another alternative for cases like this.

37 IFM data courtesy of H. Avet-Loiseau

38

39

40

41 Presentation IgA IgG FcRn Monitoring Hevylite in MM IgG IgA (Donato et al. 2011) Prognostication

42

43 Extreme Hevylite ratios IgG IgG IgG /G

44

45 Ludwig et al. Presented at ASH 2011

46

47 Any questions? Chapter 32.7

Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies

Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies Hevylite: New strategies for Diagnosis, Monitoring and Prognosis of monoclonal gammopathies AR Bradwell. University of Birmingham and Binding Site Ltd How good are tests for monoclonal monoclonal proteins?

More information

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. Learning Objectives Compare traditional

More information

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. Learning Objectives Compare traditional

More information

ABC of laboratory techniques for diagnosis and follow-up of monoclonal gammopathies. An Hendrickx MSc. Scientific Advisor

ABC of laboratory techniques for diagnosis and follow-up of monoclonal gammopathies. An Hendrickx MSc. Scientific Advisor ABC of laboratory techniques for diagnosis and follow-up of monoclonal gammopathies An Hendrickx MSc. Scientific Advisor In this talk introduction biology of free light chains laboratorium investigation

More information

Freelite & Hevylite. Together Freelite & Hevylite catch more monoclonal gammopathy patients. The Specialist Protein Company

Freelite & Hevylite. Together Freelite & Hevylite catch more monoclonal gammopathy patients. The Specialist Protein Company Freelite & Hevylite Together Freelite & Hevylite catch more monoclonal gammopathy patients The Specialist Protein Company Freelite The Freelite assay is composed of two sensitive and specific polyclonal

More information

Intact immunoglobulin heavy/light chain paired assays

Intact immunoglobulin heavy/light chain paired assays Intact immunoglobulin heavy/light chain paired assays Stephen Harding 1, Philip Young 1, Marina Di Fazio 2, Richard Hughes 1 1Research and Development, The Binding Site Group, Birmingham, UK 2Scientific

More information

Measuring Myeloma in the LAB. BL Ferry Clinical Lead Sept 15 th 2014

Measuring Myeloma in the LAB. BL Ferry Clinical Lead Sept 15 th 2014 Measuring Myeloma in the LAB BL Ferry Clinical Lead Sept 15 th 2014 Oxford Immunology Laboratory Clinical Immunology Churchill WHAT DO WE MEASURE AND HOW? Clinical Immunology Churchill Serum proteins Proteins

More information

Guidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology

Guidelines for the diagnosis of Multiple Myeloma Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Guidelines for the diagnosis of Multiple Myeloma 2014 By:British Committee for Standards in Haematology (BCSH) Ass.lec.: Dr. Karam T. Agha M.Sc.Pathology Diagnosis, prognostic factors and disease monitoring

More information

Freelite & Hevylite. Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies

Freelite & Hevylite. Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies Freelite & Hevylite Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies Monoclonal Gammopathy Monoclonal gammopathies are diseases of the bone marrow and are associated with

More information

Applicazioni della misura delle Free Light Chain nella pratica clinica. Maria Teresa Petrucci

Applicazioni della misura delle Free Light Chain nella pratica clinica. Maria Teresa Petrucci Applicazioni della misura delle Free Light Chain nella pratica clinica Maria Teresa Petrucci Serum free light chain immunoassay Heavy chain Kappa Light chain Hidden surface Lambda Exposed surface Serum

More information

Introduction. Point. Keywords: electrophoresis; Hevylite; IgA; immunoglobulin; monoclonal protein.

Introduction. Point. Keywords: electrophoresis; Hevylite; IgA; immunoglobulin; monoclonal protein. Clin Chem Lab Med 2015; aop Point Josie A.R. Evans*, Ellen L. Jenner, Hugh D. Carr Smith, Oscar Berlanga and Stephen J. Harding Quantification of β-region IgA monoclonal proteins shouldwe include immunochemical

More information

Immunoglobulin / free light chain ratio

Immunoglobulin / free light chain ratio Immunoglobulin / free light chain ratio 1 1 2 Kiyotaka FUJITA Katsunori TAKAHASHI Ikunosuke SAKURABAYASHI FLC IgG, IgA, IgM, IgD, IgE 5 1 1 H 1 L H,,,, L 2 monoclonal immunoglobulinemia : M L L H 40 H

More information

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies

Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Freelite for Measurement of Urine-Free Light Chains in Monoclonal Gammopathies Montgomery Lobe, MD, and Donald Pasquale, MD Abstract Monoclonal gammopathies are characterized by production of monoclonal

More information

Serum Free Light Chain Assays

Serum Free Light Chain Assays Freelite Serum Free Light Chain Assays An aid to the diagnosis of: Light Chain (Bence Jones) Multiple Myeloma (LCMM) Nonsecretory Multiple Myeloma (NSMM) AL amyloidosis Light Chain Deposition Disease (LCDD)

More information

Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins

Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Immunopathology / DETECTING SUBTLE FLC-PRODUCING M PROTEINS Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M Proteins Nasir A, Bakshi,

More information

Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities

Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities Immunopathology / Persistence of IFE MGUS Laboratory Persistence and Clinical Progression of Small Monoclonal Abnormalities David L. Murray, MD, PhD, 1 Justin L. Seningen, MD, 1 Angela Dispenzieri, MD,

More information

IgA Kappa/IgA Lambda Heavy/Light Chain Assessment in the Management of Patients With IgA Myeloma

IgA Kappa/IgA Lambda Heavy/Light Chain Assessment in the Management of Patients With IgA Myeloma Original Article IgA Kappa/IgA Lambda Heavy/Light Chain Assessment in the Management of Patients With IgA Myeloma Eileen M. Boyle, MD 1 ; Guillemette Fouquet, MD 1 ;Stephanie Guidez, MD 1 ; Sarah Bonnet,

More information

Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays

Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays Clinical Chemistry 61:2 360 367 (2015) Clinical Immunology Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays Jerry A. Katzmann, 1,2* Maria A.V. Willrich, 1 Mindy C. Kohlhagen, 1

More information

What do you do, with an M protein?

What do you do, with an M protein? What do you do, with an M protein? Cancer Day for Primary Care Emily Rimmer MD FRCPC January 31, 2014 emily.rimmer@cancercare.mb.ca Disclosure of Potential for Conflict of Interest Name of presenter: Emily

More information

Elevated Immunoglobulins and Paraproteins

Elevated Immunoglobulins and Paraproteins Elevated Immunoglobulins and Paraproteins NWL Pathology GP Study Afternoon Thursday 19 th October 2017 Dr Aristeidis Chaidos Consultant Haematologist and Honorary Senior Clinical Lecturer Hammersmith Hospital,

More information

Southern Derbyshire Shared Care Pathology Guidelines. Diagnosis and Management of Myeloma

Southern Derbyshire Shared Care Pathology Guidelines. Diagnosis and Management of Myeloma Southern Derbyshire Shared Care Pathology Guidelines Diagnosis and Management of Myeloma When to screen for Myeloma and related disorders Not recommended to screen the normal population Clinical Symptoms,

More information

serum FLC concentration was available twice as often as a measurable urine M-spike American Association for Clinical Chemistry

serum FLC concentration was available twice as often as a measurable urine M-spike American Association for Clinical Chemistry Clinical Chemistry 57:12 1687 1692 (2011) Clinical Immunology Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification:

More information

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels

Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels Published Ahead of Print on February 1, 2018, as doi:10.3324/haematol.2017.184226. Copyright 2018 Ferrata Storti Foundation. Cytogenetic aberrations in multiple myeloma are associated with shifts in serum

More information

June Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD

June Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD June 2011 Laboratory Evaluation of Plasma Cell Neoplasms Stan McCormick, MD In this issue we review the laboratory work up of patients suspected of having a plasma cell neoplasm. As the range in clinical

More information

Laboratories and the New IMWG Myeloma Guidelines

Laboratories and the New IMWG Myeloma Guidelines Laboratories and the New IMWG Myeloma Guidelines David F. Keren, M.D. Professor of Pathology Division Director, Clinical Pathology The University of Michigan dkeren@med.umich.edu Speaker Disclosure In

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Mateos M-V, Hernández M-T, Giraldo P, et al. Lenalidomide plus

More information

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Immunopathology / Electrophoresis of Unconcentrated Urine Samples Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples Anja C. Roden, MD,

More information

Report of Survey conducted by IFCC WG Harmonisation of Interpretive Commenting EQA (WG-ICQA) subgroup:

Report of Survey conducted by IFCC WG Harmonisation of Interpretive Commenting EQA (WG-ICQA) subgroup: Report of Survey conducted by IFCC WG Harmonisation of Interpretive Commenting EQA (WG-ICQA) subgroup: Results of an international survey of the reporting of protein electrophoresis and serum free light

More information

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Mar; 160(1): microglobulin (β 2

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Mar; 160(1): microglobulin (β 2 Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite TM ), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma Vlastimil

More information

Prognostic utility of intact immunoglobulin Ig 0 k/ig 0 l ratios in multiple myeloma patients

Prognostic utility of intact immunoglobulin Ig 0 k/ig 0 l ratios in multiple myeloma patients Leukemia (2013) 27, 202 207 & 2013 Macmillan Publishers Limited All rights reserved 0887-6924/13 www.nature.com/leu ORIGINAL ARTICLE Prognostic utility of intact immunoglobulin Ig 0 k/ig 0 l ratios in

More information

Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin / Ratios

Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin / Ratios Clinical Chemistry 55:9 1646 1655 (2009) Cancer Diagnostics Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin / Ratios Arthur R. Bradwell, 1,2* Stephen J.

More information

Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population

Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs Population Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol 36, no. 2, 2006 157 Assessment of Serum Free Light Chain Assays for Plasma Cell Disorder Screening in a Veterans Affairs

More information

WG-ICQA Harmonisation of Interpretive Commenting EQA

WG-ICQA Harmonisation of Interpretive Commenting EQA WG-ICQA Harmonisation of Interpretive Commenting EQA WG-ICQA Subgroup: Harmonisation of reporting of protein electrophoresis and serum FLC, and quantification of small monoclonal proteins Improved patient

More information

e-issn X Modern Medical Laboratory Journal

e-issn X Modern Medical Laboratory Journal Review Article Mod Med Lab J. 2018; 2(1):20-28 e-issn 2371-770X Modern Medical Laboratory Journal DOI: Serum Free Light-chain Assay for the Diagnosis, Management, and Prognosis of Multiple Myeloma Nawal

More information

EDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS

EDUCATIONAL COMMENTARY LABORATORY EVALUATION OF IMMUNOPROLIFERATIVE DISORDERS Commentary provided by: Louann W. Lawrence, Dr.PH, MLS (ASCP) Professor Emeritus, Retired Louisiana State University Health Sciences Center New Orleans, LA EDUCATIONAL COMMENTARY LABORATORY EVALUATION

More information

Diagnosis and Current Standard Treatments for Multiple Myeloma. Natalie S. Callander, M.D Professor of Medicine

Diagnosis and Current Standard Treatments for Multiple Myeloma. Natalie S. Callander, M.D Professor of Medicine Diagnosis and Current Standard Treatments for Multiple Myeloma Natalie S. Callander, M.D Professor of Medicine Goals Introduce and/or compliment understanding of plasma cell disorders-mgus, SMM and symptomatic

More information

Understanding Lab Values in Multiple Myeloma

Understanding Lab Values in Multiple Myeloma Understanding Lab Values in Multiple Myeloma A reference guide to the common laboratory tests used in the diagnosis and monitoring of multiple myeloma Differential Diagnosis Multiple Myeloma (MM) Is a

More information

Myeloma Primary Care. Dr R Lovell Feb 2015

Myeloma Primary Care. Dr R Lovell Feb 2015 Myeloma Primary Care Dr R Lovell Feb 2015 Aims Balance of pathophysiology and cases Explain diagnostic changes (minimal) Staging UK influence Autologous stem cell transplants Primary care myeloma problems

More information

ד"ר יעל דויטשר-צ'רטקוב,

דר יעל דויטשר-צ'רטקוב, הביולוגי ועקרון המדידה של הבסיס Free Light בסרום Chains רמות ד"ר יעל דויטשר-צ'רטקוב, המעבדה ההמטולוגית, רמב"ם - הקריה הרפואית לבריאות האדם Free light chains: Facts and Numbers Plasma cells 2 Kappa : 1

More information

Smoldering Multiple Myeloma

Smoldering Multiple Myeloma Smoldering Multiple Myeloma S. Vincent Rajkumar Professor of Medicine Mayo Clinic Scottsdale, Arizona Rochester, Minnesota Jacksonville, Florida Mayo Clinic College of Medicine Mayo Clinic Comprehensive

More information

Leukemia (2013) 27, & 2013 Macmillan Publishers Limited All rights reserved /13

Leukemia (2013) 27, & 2013 Macmillan Publishers Limited All rights reserved /13 Leukemia (2013) 27, 213 219 & 2013 Macmillan Publishers Limited All rights reserved 0887-6924/13 www.nature.com/leu ORIGINAL ARTICLE Immunoglobulin heavy/light chain ratios improve paraprotein detection

More information

Evaluation of Sebia s Capillarys 2 flex-piercing system in. level monoclonal protein in serum and urine of patients

Evaluation of Sebia s Capillarys 2 flex-piercing system in. level monoclonal protein in serum and urine of patients Peer reviewed ORIGINAL ARTICLE Evaluation of Sebia s Capillarys 2 flex-piercing system in comparison with Hydrasys gel system, in identifying low level monoclonal protein in serum and urine of patients

More information

diag.of gammop Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS

diag.of gammop Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS laboratory diag.of gammop Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS Sarrafnejad@tums.ac.ir Arne Wilhelm Kaurin Tiselius Nobel Prize for Chemistry (1948) Electrophoresis ٤ After

More information

Effective Health Care Program

Effective Health Care Program Comparative Effectiveness Review Number 73 Effective Health Care Program Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background

More information

Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple Myeloma

Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple Myeloma Clinical Chemistry 56:1 16 20 (2010) Clinical Case Study Sharply Increased Serum Free Light-Chain Concentrations after Treatment for Multiple Myeloma Kazunori Murata, 1 Raynell J. Clark, 1 Karen S. Lockington,

More information

DIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP

DIAGNOSIS OF MYELOMA BASED ON THE 2014 INTERNATIONAL MYELOMA WORKING GROUP INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Majalah Patologi Klinik Indonesia dan Laboratorium Medik Page 196 2018 March; 24(2): 196-200 p-issn 0854-4263 e-issn 2477-4685 Available

More information

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma Wang et al. BMC Cancer (2018) 18:650 https://doi.org/10.1186/s12885-018-4562-8 RESEARCH ARTICLE Open Access Detection of intracellular IgD using flow cytometry could be a novel and supplementary method

More information

Restrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials

Restrooms Cell phones on silent/vibrate. Refreshments. Patient resource materials Restrooms Cell phones on silent/vibrate Refreshments Patient resource materials This presentation should not replace discussions with your healthcare provider, but seeks to provide information and resources

More information

Current Issues in Pharmacy and Medical Sciences. journal homepage:

Current Issues in Pharmacy and Medical Sciences. journal homepage: Curr. Issues Pharm. Med. Sci., Vol., No., Pages 5- Current Issues in Pharmacy and Medical Sciences Formerly ANNALES UNIVERSITATIS MARIAE CURIE-SKLODOWSKA, SECTIO DDD, PHARMACIA journal homepage: http://www.curipms.umlub.pl/

More information

Current Issues in Pharmacy and Medical Sciences. journal homepage:

Current Issues in Pharmacy and Medical Sciences. journal homepage: Curr. Issues Pharm. Med. Sci., Vol., No., Pages 5- Current Issues in Pharmacy and Medical Sciences Formerly ANNALES UNIVERSITATIS MARIAE CURIE-SKLODOWSKA, SECTIO DDD, PHARMACIA journal homepage: http://www.curipms.umlub.pl/

More information

Diagnosis and staging

Diagnosis and staging Chapter 2 Diagnosis and staging Carlos Fernández de Larrea and Joan Bladé Diagnostic criteria Multiple myeloma (MM) is a plasma cell disorder characterized by a clonal proliferation of cells producing

More information

بسم اهلل الرمحن الرحيم

بسم اهلل الرمحن الرحيم بسم اهلل الرمحن الرحيم Definition Multiple myeloma is a neoplastic plasma cell dyscrasia (PCD) that generally produced a monoclonal immunoglobulin protein, characterized by a clinical pentad: (a) anemia;

More information

Electrophoresis. Assays... INTERLAB ASSAYS. Instrument. Software Easy data management thanks to innovative Elfolab software. General Characteristic

Electrophoresis. Assays... INTERLAB ASSAYS. Instrument. Software Easy data management thanks to innovative Elfolab software. General Characteristic Software Easy data management thanks to innovative Elfolab software. Instrument Complete walk-away automation. Initial 52 results available within 50 minutes. Impressive 208 Serum Proteins samples per

More information

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed.

This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed. MGUS This Infosheet explains what Monoclonal Gammopathy of Undetermined Significance (MGUS) is and how it is diagnosed and managed. What is MGUS? Monoclonal gammopathy of undetermined significance, or

More information

Q1 What is your occupation/role? (select all that apply) Answered: 310 Skipped: 4 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

Q1 What is your occupation/role? (select all that apply) Answered: 310 Skipped: 4 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Q1 What is your occupation/role? (select all that apply) Answered: 310 Skipped: 4 ANSWER CHOICES Pathologist Total Respondents: 310 Pathologist Physician (non-radiolo... Medical Director Technologist/Te

More information

Performance of the Sebia CAPILLARYS 2 for Detection and Immunotyping of Serum Monoclonal Paraproteins

Performance of the Sebia CAPILLARYS 2 for Detection and Immunotyping of Serum Monoclonal Paraproteins Immunopathology / SEBIA CAPILLARYS 2 PARAPROTEIN DETECTION Performance of the Sebia CAPILLARYS 2 for Detection and Immunotyping of Serum Monoclonal Paraproteins Zhaohai Yang, MD, PhD, Keith Harrison, MD,

More information

Handout for lecture on plasma cell neoplasms presented by Rob McKenna

Handout for lecture on plasma cell neoplasms presented by Rob McKenna Handout for lecture on plasma cell neoplasms presented by Rob McKenna The following slides represent a near final version of the presentation that will be given in Maui, January 23,2018. Minor changes

More information

Analytically coherent

Analytically coherent ZO M OCTOBER 2017 N 7 sebia FLC Free light chain testing coherent with electrophoretic methods Analytically coherent SPE: 3.1 g/l FLC Nephelometry: 32.2 g/l FLC ELISA: 3.1 g/l Principle The sebia FLC Kappa

More information

Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio

Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio Elmer ress Original Article J Clin Med Res. 2017;9(1):46-57 Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio Gurmukh

More information

Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder

Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder research paper Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder Pieter Vermeersch, 1 * Lieve Van Hoovels, 1 * Michel Delforge, 2 Godelieve

More information

Brian GM Durie. Black Swan Research Initiative (BSRI) Purpose

Brian GM Durie. Black Swan Research Initiative (BSRI) Purpose Black Swan Research Initiative Brian GM Durie Saturday August 22, 2015 1 Black Swan Research Initiative (BSRI) Purpose The Black Swan Research Initiative (BSRI) is a global collaborative approach Which

More information

Relatively Restricted Migration of Polyclonal IgG4 May Mimic a Monoclonal Gammopathy in IgG4-Related Disease

Relatively Restricted Migration of Polyclonal IgG4 May Mimic a Monoclonal Gammopathy in IgG4-Related Disease Relatively Restricted Migration of Polyclonal 4 May Mimic a Monoclonal Gammopathy in 4-Related Disease Joannes F. M. Jacobs, MD, PhD, 1,2 Renate G. van der Molen, PhD, 1 and David F. Keren, MD, PhD 3 From

More information

Available online at

Available online at Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 45, no. 2, 2015 193 The Utility of The Serum Heavy/Light Chain Assay as a Complementary Tool in the Monitoring of

More information

Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management

Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management Ellen L. Jenner, 1 Josie A.R. Evans, 1 and Stephen J. Harding 1 * Background: Monoclonal free light chains (FLCs)

More information

Parameswaran Hari Medical College of Wisconsin Milwaukee

Parameswaran Hari Medical College of Wisconsin Milwaukee Multiple Myeloma Linking the clinical course to report forms Parameswaran Hari Medical College of Wisconsin Milwaukee 45,000 Annual Numbers of Blood and Marrow Transplants Worldwide 1970-2003 40,000 Number

More information

Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias

Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias DRAFT Comparative Effectiveness Review Number xx Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias Prepared for: Agency for Healthcare Research and

More information

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline:

Smouldering myeloma. Myeloma Infosheet Series. Other related conditions. Infoline: Smouldering myeloma This Infosheet provides information on what smouldering myeloma is, how it is diagnosed, what the treatment is and will explain the link between smouldering myeloma and active myeloma.

More information

Serum free light chain and Hevylite analyses in the diagnosis, monitoring and prognosis of B cell disorders

Serum free light chain and Hevylite analyses in the diagnosis, monitoring and prognosis of B cell disorders Klin. Biochem. Metab., 18 (39), 2010, No. 2, p. 56 61. Serum free light chain and Hevylite analyses in the diagnosis, monitoring and prognosis of B cell disorders Legg A. 1, Harding S. 1, Hughes R. G.

More information

Hot Topic. Disclosures. None

Hot Topic. Disclosures. None Hot Topic Multiple Myeloma Testing at Mayo Medical Laboratories HOT TOPIC / 2017 MFMER 1 Our speaker for this program is Dragan Jevremovic, MD, PhD Assistant Professor, Division of Hematopathology at Mayo

More information

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy Hutchison et al. BMC Clinical Pathology 2012, 12:12 TECHNICAL ADVANCE Open Access Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy

More information

Accuracy of Serum IgM and IgA Monoclonal Protein Measurements by Densitometry

Accuracy of Serum IgM and IgA Monoclonal Protein Measurements by Densitometry 160 Annals of Clinical & Laboratory Science, vol. 33, no. 2, 2003 Accuracy of Serum IgM and IgA Monoclonal Protein Measurements by Densitometry C. Howard Tseng, 1 Chin-Yung Chang, 2 Kevin S. Liu, 3 and

More information

Serum Free Light Chain Analysis

Serum Free Light Chain Analysis Serum Free Light Chain Analysis Rajeevan Selvaratnam, Jing Cao and Amy B. Karger Introduction In healthy individuals, plasma cells originating from the bone marrow produce immunoglobulin molecules composed

More information

Minimal Residual Disease assessment in Multiple Myeloma by Next-Generation Sequencing

Minimal Residual Disease assessment in Multiple Myeloma by Next-Generation Sequencing Minimal Residual Disease assessment in Multiple Myeloma by Next-Generation Sequencing Prof Hervé AVET-LOISEAU, : MD, PhD Institut Universitaire du Cancer Toulouse, France MRD Meta-Analysis in Myeloma Nikhil

More information

IMMUNOCHEMICAL TECHNIQUES

IMMUNOCHEMICAL TECHNIQUES 24 IMMUNOCHEMICAL TECHNIQUES 24.1 INTRODUCTION All vertebrates have advanced immune system. The more complex the organism the more advanced the immune system. The immune system of mammals has evolved over

More information

Change Summary - Form 2116 (R3) 1 of 6

Change Summary - Form 2116 (R3) 1 of 6 Change Summary - Form 2116 (R3) 1 of 6 Form Question Number (r3) Question Text Change Type Description New Text Previous Text Previous Question Number (r2) 2116 Today's date: Removed "Today's date:" was

More information

Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation

Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation Original Article Significance of Abnormal Protein Bands in Patients with Multiple Myeloma following Autologous Stem Cell Transplantation Sara L. Hall, 1 Jill Tate, 2 Devinder Gill, 1,3 *Peter Mollee 1,3

More information

HEALTHTREE QUESTIONNAIRE

HEALTHTREE QUESTIONNAIRE HEALTHTREE QUESTIONNAIRE PLEASE ASK YOUR NURSE OR HEALTH CARE TEAM IF YOU NEED HELP COMPLETING THE FORM Name Date: PRIOR MYELOMA START STOP TYPE OF DID THE DOCTOR ADD OR REMOVE A DRUG OR CHANGE YOUR DOSE?

More information

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma Robert A. Kyle, M.D., Ellen D. Remstein, M.D., Terry

More information

Jerry A. Katzmann, 1* Raynell J. Clark, 1 Roshini S. Abraham, 1 Sandra Bryant, 1 James F. Lymp, 1 Arthur R. Bradwell, 2 and Robert A. Kyle 1.

Jerry A. Katzmann, 1* Raynell J. Clark, 1 Roshini S. Abraham, 1 Sandra Bryant, 1 James F. Lymp, 1 Arthur R. Bradwell, 2 and Robert A. Kyle 1. Clinical Chemistry 48:9 1437 1444 (2002) Enzymes and Protein Markers Serum Reference Intervals and Diagnostic Ranges for Free and Free Immunoglobulin Light Chains: Relative Sensitivity for Detection of

More information

The New England Journal of Medicine A LONG-TERM STUDY OF PROGNOSIS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE. Patients

The New England Journal of Medicine A LONG-TERM STUDY OF PROGNOSIS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE. Patients A LONG-TERM STUDY OF PROGNOSIS IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE ROBERT A. KYLE, M.D., TERRY M. THERNEAU, PH.D., S. VINCENT RAJKUMAR, M.D., JANICE R. OFFORD, B.S., DIRK R. LARSON, M.S.,

More information

SIGNIFICANCE OF GAMMA GLOBULINS IN MULTIPLE MYELOMA THROUGH SERUM ELECTROPHORETIC PATTERN

SIGNIFICANCE OF GAMMA GLOBULINS IN MULTIPLE MYELOMA THROUGH SERUM ELECTROPHORETIC PATTERN WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Kumar et al. SJIF Impact Factor 6.647 Volume 6, Issue 7, 1211-1218 Research Article ISSN 2278 4357 SIGNIFICANCE OF GAMMA GLOBULINS IN MULTIPLE MYELOMA

More information

Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM

Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic IgM Hindawi Publishing Corporation Case Reports in Hematology Volume 2014, Article ID 676913, 5 pages http://dx.doi.org/10.1155/2014/676913 Case Report Serum Free Light Chain Only Myeloma with Cytoplasmic

More information

Monitoring Multiple Myeloma

Monitoring Multiple Myeloma Monitoring Multiple Myeloma Kyle A. Udd, BS, Tanya M. Spektor, PhD, and James R. Berenson, MD Mr Udd is a medical research data analyst at the Institute for Myeloma & Bone Cancer Research in West Hollywood,

More information

Diagnosis of multiple myeloma (MM) requires the examination

Diagnosis of multiple myeloma (MM) requires the examination TECHNIQUES FOR EVALUATION OF PATIENTS WITH MULTIPLE MYELOMA New Tools for Diagnosis and Monitoring of Multiple Myeloma Jesús F. San-Miguel, MD, PhD, Bruno Paiva, PhD, and Norma C. Gutiérrez, MD, PhD OVERVIEW

More information

Polyclonal versus monoclonal immunoglobulin-free light chains quantification

Polyclonal versus monoclonal immunoglobulin-free light chains quantification Original Article Annals of Clinical Biochemistry 2015, Vol. 52(3) 327 336! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/0004563214553808 acb.sagepub.com

More information

The Importance of Establishing Baseline Disease Characteristics in Myeloma Diagnosis and Management

The Importance of Establishing Baseline Disease Characteristics in Myeloma Diagnosis and Management I am Dr. Brian Durie at Cedars Sinai Medical Center, Los Angeles. I am also chairman of the International Myeloma Foundation, and I am very pleased today to be participating in this program with my friend

More information

Understanding MGUS and Smoldering Multiple Myeloma

Understanding MGUS and Smoldering Multiple Myeloma Multiple Myeloma Cancer of the Bone Marrow Understanding MGUS and Smoldering Multiple Myeloma u-mgus+smm_en_2017_i1 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE

More information

Management of Multiple Myeloma: The Changing Paradigm

Management of Multiple Myeloma: The Changing Paradigm Management of Multiple Myeloma: The Changing Paradigm Myeloma 101: Disease Overview Hans Lee, MD Assistant Professor Department of Lymphoma/Myeloma University of Texas MD Anderson Cancer Center No Disclosures

More information

Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients

Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients Juana J. Jiménez, 1 * Tiago M. Pais, 2 Nuno Barbosa, 2 Maria Luisa Campos, 2 Maria Antonia Peñalver

More information

Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity

Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity 274 Annals of Clinical & Laboratory Science, vol. 31, no. 3, 2001 Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity Liang Wang and David C. Young Department of

More information

A rare case of non-secretory multiple myeloma: a case report and literature review

A rare case of non-secretory multiple myeloma: a case report and literature review This is a Platinum Open Access Journal distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction

More information

+ Serum Protein Electrophoresis with Immunofixation

+ Serum Protein Electrophoresis with Immunofixation + Serum Protein Electrophoresis with Immunofixation Dr.Ajay Phadke Centre Head SRL Diagnostics-Dr.Avinash Phadke s Lab + What is electrophoresis? Electrophoresis is a method of separating proteins based

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart

More information

Professor Mitch Dowsett. Dr Martin Kaiser Dr Robyn Shea Dr Robyn Shea. Molecular Pathology Biochemistry

Professor Mitch Dowsett. Dr Martin Kaiser Dr Robyn Shea Dr Robyn Shea. Molecular Pathology Biochemistry The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL PROJECT DETAILS Project Title: SUPERVISORY TEAM Primary Supervisor(s): Dried Blood Spot Analysis of Heavy/Light and Free Light Chains to

More information

Index. Quinzanini, M. Departments of Rheumatology, Immunology & Allergology, Azienda Ospedaliera Spedali Civili, Brescia, Italy

Index. Quinzanini, M. Departments of Rheumatology, Immunology & Allergology, Azienda Ospedaliera Spedali Civili, Brescia, Italy Poster from the Congress EUROMEDLAB Barcelona, 1-5 June 2003 15 th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine 22 nd National Congress of the Spanish Society of Clinical

More information

Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort

Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort pissn 1598-2998, eissn 2005-9256 Cancer Res Treat. 2015;47(2):5-220 Original Article http://dx.doi.org/10.4143/crt.2013.262 Open Access Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined

More information

Monoclonal gammopathies overview and categorization

Monoclonal gammopathies overview and categorization Clin Chem Lab Med 2016; 54(6): 907 919 Review Maria A.V. Willrich* and Jerry A. Katzmann Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias

More information

CHAPTER 3 ANTIBODY STRUCTURE I

CHAPTER 3 ANTIBODY STRUCTURE I CHAPTER 3 ANTIBODY STRUCTURE I See APPENDIX: (3) OUCHTERLONY ANALYSIS; (6), EQUILIBRIUM DIALYSIS; (7) CROSS-REACTIVITY Electrophoretic separation of serum proteins identifies the GAMMA-GLOBULIN fraction

More information

SAS-MX IFE-1 Kit Instructions for Use

SAS-MX IFE-1 Kit Instructions for Use SAS-MX IFE-1 Kit Instructions for Use Queensway South, Team Valley Trading Estate, 100300 Gateshead, Tyne and Wear, NE11 0SD, United Kingdom Tel: +44 (0)191 482 8440 Fax: +44 (0)191 482 8442 Email: info@helena-biosciences.com

More information